EA200701800A1 - Применение производного пиразола для получения лекарственных средств, подходящих для профилактики и лечения заболеваний почек - Google Patents

Применение производного пиразола для получения лекарственных средств, подходящих для профилактики и лечения заболеваний почек

Info

Publication number
EA200701800A1
EA200701800A1 EA200701800A EA200701800A EA200701800A1 EA 200701800 A1 EA200701800 A1 EA 200701800A1 EA 200701800 A EA200701800 A EA 200701800A EA 200701800 A EA200701800 A EA 200701800A EA 200701800 A1 EA200701800 A1 EA 200701800A1
Authority
EA
Eurasian Patent Office
Prior art keywords
prevention
treatment
derivative
pyrazol
production
Prior art date
Application number
EA200701800A
Other languages
English (en)
Other versions
EA011655B1 (ru
Inventor
Мохаммед Бенсаид
Жан-Марк Эрбер
Филип Жаниак
Original Assignee
Санофи-Авентис
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0501919A external-priority patent/FR2882262B1/fr
Application filed by Санофи-Авентис filed Critical Санофи-Авентис
Publication of EA200701800A1 publication Critical patent/EA200701800A1/ru
Publication of EA011655B1 publication Critical patent/EA011655B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Применение антагониста каннабиноидных рецепторов CB, являющегося производным пиразола, самостоятельно или вместе с другим активным веществом, для получения лекарственных средств, подходящих для профилактики и лечения заболеваний почек.
EA200701800A 2005-02-23 2006-02-17 Применение производного пиразола для получения лекарственных средств, подходящих для профилактики и лечения заболеваний почек EA011655B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0501919A FR2882262B1 (fr) 2005-02-23 2005-02-23 Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement des maladies renales
FR0504798A FR2882263B1 (fr) 2005-02-23 2005-05-12 Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement des maladies renales
PCT/FR2006/000369 WO2006090047A1 (fr) 2005-02-23 2006-02-17 Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement des maladies renales

Publications (2)

Publication Number Publication Date
EA200701800A1 true EA200701800A1 (ru) 2008-02-28
EA011655B1 EA011655B1 (ru) 2009-04-28

Family

ID=36603585

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200701800A EA011655B1 (ru) 2005-02-23 2006-02-17 Применение производного пиразола для получения лекарственных средств, подходящих для профилактики и лечения заболеваний почек

Country Status (18)

Country Link
US (1) US7622488B2 (ru)
EP (1) EP1855675A1 (ru)
JP (1) JP2008531526A (ru)
KR (1) KR20070104916A (ru)
AR (1) AR054003A1 (ru)
AU (1) AU2006217794A1 (ru)
BR (1) BRPI0607894A2 (ru)
CA (1) CA2597802A1 (ru)
CR (1) CR9270A (ru)
EA (1) EA011655B1 (ru)
FR (1) FR2882263B1 (ru)
IL (1) IL185165A0 (ru)
MA (1) MA29263B1 (ru)
MX (1) MX2007009995A (ru)
NO (1) NO20074768L (ru)
TN (1) TNSN07291A1 (ru)
TW (1) TW200640458A (ru)
WO (1) WO2006090047A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010079241A1 (es) 2009-01-12 2010-07-15 Fundacion Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion Uso de antagonistas y/o agonistas inversos de los receptores cb1 para la preparación de medicamentos que incrementen la excitabilidad de las motoneuronas
FR2958850B1 (fr) * 2010-04-14 2012-07-06 Centre Nat Rech Scient Medicaments pour la prevention ou le traitement des addictions aux drogues

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2713225B1 (fr) * 1993-12-02 1996-03-01 Sanofi Sa N-pipéridino-3-pyrazolecarboxamide substitué.
FR2692575B1 (fr) * 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2789079B3 (fr) * 1999-02-01 2001-03-02 Sanofi Synthelabo Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
US20040122033A1 (en) * 2002-12-10 2004-06-24 Nargund Ravi P. Combination therapy for the treatment of obesity
US20040214804A1 (en) * 2003-04-25 2004-10-28 Pharmacia Corporation Combination of an aldosterone receptor antagonist and an anti-obesity agent
AR051446A1 (es) * 2004-09-23 2007-01-17 Bristol Myers Squibb Co Glucosidos de c-arilo como inhibidores selectivos de transportadores de glucosa (sglt2)

Also Published As

Publication number Publication date
EP1855675A1 (fr) 2007-11-21
KR20070104916A (ko) 2007-10-29
WO2006090047A1 (fr) 2006-08-31
AU2006217794A1 (en) 2006-08-31
FR2882263B1 (fr) 2007-04-06
TNSN07291A1 (en) 2008-12-31
EA011655B1 (ru) 2009-04-28
IL185165A0 (en) 2008-06-05
MX2007009995A (es) 2007-10-10
JP2008531526A (ja) 2008-08-14
CR9270A (es) 2007-10-01
BRPI0607894A2 (pt) 2009-10-20
NO20074768L (no) 2007-11-23
CA2597802A1 (fr) 2006-08-31
MA29263B1 (fr) 2008-02-01
AR054003A1 (es) 2007-05-30
TW200640458A (en) 2006-12-01
FR2882263A1 (fr) 2006-08-25
US20080015228A1 (en) 2008-01-17
US7622488B2 (en) 2009-11-24

Similar Documents

Publication Publication Date Title
NO20091299L (no) Substituerte sulfonamidderivater
NO20064041L (no) Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
EA200802322A1 (ru) Производные фенилпиразола в качестве нестероидных лигандов глюкокортикоидных рецепторов
EA200970595A1 (ru) Производные замещенных индазолов, активные в качестве ингибиторов киназ
CL2007000601A1 (es) Compuestos derivados de heterobiciclos pirazolicos, inhibidores de la actividad de proteina tiroxina quinasa; composicion farmaceutica que comprende dichos compuestos; y uso de los compuestos en el tratamiento de una enfermedad hiperproliferativa.
EP1571147A3 (en) Pyrazole analogs acting on cannabinoid receptors
WO2007020502A3 (en) Cannabinoid receptor ligands and uses thereof
WO2008043544A8 (en) Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
EA200971077A1 (ru) Гетероциклические модуляторы киназы
EA201070167A1 (ru) Замещенные производные индазола, активные как ингибиторы киназы
NO20090295L (no) Substituerte heteroarylderivater
EA200901442A1 (ru) Комбинированная терапия соединением, проявляющим активность ингибитора рецептора адф на тромбоцитах
EA200600647A1 (ru) Соединения бициклических пиразолила и имидазолила и их применение
CY1112429T1 (el) Υποκατεστημενα παραγωγα σουλφοναμιδιου
BRPI0512974A (pt) novos derivados de hidantoìna para o tratamento de doenças obstrutivas das vias aéreas
TW200745043A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
TW200738699A (en) 4-Substituted pyrazoline compounds, their preparation and use as medicaments
ATE543804T1 (de) Neue verbindungen
TW200714603A (en) Acylaminobicyclic heteroaromatic compounds and uses thereof
RS51069B (sr) Upotreba oksikodona za tretiranje visceralnog bola
CY1116840T1 (el) Χρηση 24-norudca
EA200801425A1 (ru) Диазепиноны
WO2007009686A3 (en) Substituted pyrazoline compounds, their preparation and use as medicaments
WO2007009691A3 (en) Combination of substituted pyrazolines and anti -addictive agent

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU